Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9393 - 9400 of 11442 results
Strategies for Efficiently Obtaining Antitrust Clearance
November 20, 2014| Blog| Viewpoint
Vascular Solutions Inc. and its CEO Face Criminal Charges for Selling Unapproved Medical Devices
November 20, 2014| Blog| Viewpoint
CPSC Focusing on Three Areas for Reduction of CPSIA Testing Burdens
November 19, 2014| Blog| Viewpoint
Upcoming Change in Documentary Transfer Tax Disclosure in California
November 19, 2014| Blog| Viewpoint
Halliburton's Acquisition of Baker Hughes Likely to Receive Close Antitrust Scrutiny from Department of Justice
November 19, 2014| Blog| Viewpoint
The Seventh Circuit Rejects Medicaid False Claims Act Suit
November 19, 2014| Blog| Viewpoint
The 340B Mega-Reg is Dead
November 19, 2014| Blog| Viewpoint
ML Strategies Energy and Environment Update: Week of 11/17/2014
November 18, 2014| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.